Director Of New Health Agency Program Determined To Elevate Status Of Minority Biomedical Scientists

Elevate Status Of Minority Biomedical Scientists Author: KAREN YOUNG KREEGER, pp.1 Date: July 11,1994 Researchers, National Institutes of Health administrators, and government officials say the first director of a newly created NIH minority-support program is a fitting choice to lead an office whose creation is long overdue. The new leader is appropriate, they say, because he is both a veteran advocate of minorities in science and

Written byKaren Kreeger
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Elevate Status Of Minority Biomedical Scientists Author: KAREN YOUNG KREEGER, pp.1
Date: July 11,1994

Researchers, National Institutes of Health administrators, and government officials say the first director of a newly created NIH minority-support program is a fitting choice to lead an office whose creation is long overdue. The new leader is appropriate, they say, because he is both a veteran advocate of minorities in science and a minority scientist who has experienced the ups and downs of federal science funding.

Supporters say Clifton A. Poodry is an apt choice to head the Minority Opportunities in Research program because of his relevant personal as well as professional experiences. For example, the 50-year-old member of the Tonawanda Seneca Indian tribe served on the boards of directors of both the American Indian Science and Engineering Society (AISES), based in Boulder, Colo., and the Society for the Advancement of Chicanos and Native Americans in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies